Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 1, 2000, Pages 97-104

  Kanarek, Robin B ^a   Homoleski, Brent A ^a   Wiatr, Claudia ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Analgesia; Antinociception; Food intake; Kappa opioid receptors; Palatability; Rats; Spiradoline; Sucrose; Tail flick test

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; SPIRADOLINE; SUCROSE; U 62055; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; MALE; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TAIL FLICK TEST;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; FEMALE; MALE; PYRROLIDINES; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, KAPPA; SEX FACTORS; SUCROSE;

ANIMALIA;

EID: 0033958163     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00181-1     Document Type: Article

References (57)

1. Abbot F.V., Melzack R., Samuel C. Morphine analgesia in the tail flick and formalin pain test is mediated by different neural systems. Exp. Neurol. 75:1982;644-651.
2. Ali B., Sharif S., Elkadi A. Sex differences and the effect of gonadectomy on morphine-induced antinociception and dependence in rats and mice. Clin. Exp. Pharmacol. Physiol. 22:1995;342-344.
3. Aloisi A.M., Steenbergen H.L., Van De Poll N.E., Farabolli F. Sex-dependent effects on restraint on nociception and pituitary-adrenal hormones in the rat. Physiol. Behav. 55:1994;789-793.
4. Antal M., Nagy K., Bedo M.B. Effect of dietary carbohydrate and ethanol on the activity of microsomal drug-metabolizing enzymes in rat liver. Ann. Nutr. Metab. 25:1981;239-244.
5. Baamonde A., Hidalgo A., Andres-Trelles F. Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology. 28:1989;957-970.
6. Bartok R.E., Craft R.M. Sex differences in opioid antinociception. J. Pharmacol. Exp. Ther. 282:1997;769-778.
7. Berge O.G., Garcia Cabrera I., Hole K. Response latencies in the tail-flick test depend on tail skin temperature. Neurosci. Lett. 86:1988;284-288.
8. Briggs S.L., Rech R.H., Sawyer D.C. Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats. Pharmacol. Biochem. Behav. 60:1998;467-472.
9. Castonguay T.W., Hirsch E., Collier G. Palatability of sugar solutions and dietary selection. Physiol. Behav. 27:1981;7-12.
10. Cicero T.J. Gender-related differences in the antinociceptive properties of morphine. J. Pharmacol. Exp. Ther. 279:1996;767-773.
11. Cicero T.J., Nock B., Meyer E.R. Sex-related differences in morphine's antinociceptive activity. Relationship to serum and brain morphine concentrations J. Pharmacol. Exp. Ther. 282:1997;939-944.
12. Cleary J., Weldon D.T., O'Hare E., Billington C., Levine A.S. Naloxone effects on sucrose-motivated behavior. Psychopharmacology (Berlin). 126:1996;110-114.
13. Cooper S.J., Jackson A., Kirkham T.C. Endorphins and food intake. Kappa opioid receptor agonists and hyperphagia Pharmacol. Biochem. Behav. 23:1985;889-901.
14. Cooper S.J., Jackson A., Morgan R., Carger R. Evidence for opiate receptor involvement in the consumption of a high palatability diet in nondeprived rats. Neuropeptides. 5:1985;345-348.
15. D'Anci K.E., Kanarek R.B., Marks-Kaufman R. Beyond sweet taste. Saccharin, sucrose, and polycose differ in their effects upon morphine-induced analgesia Pharmacol. Biochem. Behav. 56:1997;341-345.
16. D'Anci K.E., Kanarek R.B., Marks-Kaufman R. Duration of sucrose availability differentially alters morphine-induced analgesia in rats. Pharmacol. Biochem. Behav. 54:1996;693-697.
17. Dum J., Gramsch C.H., Herz A. Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food. Pharmacol. Biochem. Behav. 18:1983;443-447.
18. Eide P.K., Berge O.G., Tjolsen A., Hole K. Apparent hyperalgesia in the mouse tail-flick test due to increased tail skin temperature after lesioning of serotonergic pathways. Acta Physiol. Scand. 134:1988;413-420.
19. Foulds-Mathes W., Monfared L., Kanarek R.B. Ingestion of sucrose enhances centrally administered mu and delta but not kappa opiate-induced analgesia. Soc. Neurosci. Abstr. 23:1997;527.
20. Frye C.A., Cuevas C.A., Kanarek R.B. Diet and estrous cycle influence pain sensitivity in rats. Pharmacol. Biochem. Behav. 45:1993;255-260.
21. Hewson G., Hill R.G., Hughes J., Leighton G.E., Turner W.D. The kappa agonists PD117302 and U50488 produce a biphasic effect on 24 hour food intake in the rat. Neuropharmacology. 26:1987;1581-1584.
22. Homoleski, B.; Udaka, I. J.; Bockian, N.; Kanarek, R. B.: Sucrose enhances opioid-induced analgesia in a novel analgesic paradigm. Soc. Neurosci. Abstr. 24:1928; 1998.
23. Islem A., Cooper M., Bodnar R. Interaction among aging, gender and gonadectomy effects upon morphine antinociception in rats. Physiol. Behav. 54:1993;45-53.
24. Jackson A., Cooper S.J. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads. Brain Res. Bull. 15:1985;391-396.
25. Kanarek R.B., Hirsch E. Dietary-induced overeating in experimental animals. Fed. Proc. 36:1977;154-158.
26. Kanarek R.B., Marks-Kaufman R. Animal models of appetitive behavior. Interaction of nutritional factors and drug seeking behavior Winick M. Control of appetite. 1988;1-25 Alan R. Liss, New York.
27. Kanarek R.B., D'Anci K.E., Przypek J.M., Foulds-Mathes W. Altering dietary levels of protein or vitamins and minerals does not modify morphine-induced analgesia in male rats. Pharmacol. Biochem. Behav. 62:1999;203-208.
28. Kanarek R.B., Methes W.F., Heisler L.K., Lima R.P., Monfared L.S. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats. Pharmacol. Biochem. Behav. 57:1997;377-381.
29. Kanarek R.B., Przypek J., D'Anci K.E., Marks-Kaufman R. Dietary modulation of mu- and kappa-opioid receptor mediated analgesia. Pharmacol. Biochem. Behav. 8:1997;43-49.
30. Kanarek R.B., White E.S., Biegen M.T., Marks-Kaufman R. Dietary influences on morphine-induced analgesia in rats. Pharmacol. Biochem. Behav. 38:1991;681-684.
31. Kanarek, R. B.; Homoleski, B.: Gender differences in the modulation of morphine-induced analgesia by palatable solutions. Pharmacol. Biochem. Behav. (submitted).
32. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 34:1989;119-127.
33. Kepler K.L., Standifer K.M., Paul D., Kest B., Pasternak G.W., Bodnar R.J. Gender effects and central opioid analgesia. Pain. 45:1991;87-94.
34. Kirkham T.C., Cooper S.J. Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44:1988;491-494.
35. Kunihara M., Ohyama M., Nakano M. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective κ-opioid receptor agonist. Eur. J. Pharmacol. 214:1992;111-118.
36. Kunihara M., Ohyama M., Nakano M. Effects of spiradoline mesylate, a selective κ-opioid receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia. Jpn. J. Pharmacol. 62:1993;223-230.
37. Kunihara M., Ohyama M., Nakano M., Hayashi S. Analgesic activity of spiradoline mesylate (U62,066E), a kappa opioid agonist in mice. Life Sci. 45:1989;1191-1198.
38. Lee M.D., Clifton P.G. Free-feeding and free-drinking patterns of male rats following treatment with opiate kappa agonists. Physiol. Behav. 52:1992;1179-1185.
39. Levine A.S., Weldon D.T., Grace M., Cleary J.P., Billington C.J. Naloxone blocks that portion of feeding that is driven by sweet taste in food-restricted rats. Am. J. Physiol. 268:1995;R248-R252.
40. Marks-Kaufman R., Hamm M.W., Barbato G.F. The effects of dietary sucrose on opiate receptor binding in genetically obese (ob/ob) and lean mice. J. Am. Coll. Nutr. 8:1989;9-14.
41. Nikfar S., Abdollahi M., Etemad F., Sharifzadeh M. Effects of sweetening agents on morphine-induced analgesia in mice by formalin test. Gen. Pharmacol. 29:1997;583-586.
42. Nikfar S., Abdollahi M., Sarkarati F., Etemad F. Interaction between calcium channel blockers and sweetening agents on morphine-induced analgesia in mice by formalin test. Gen. Pharmacol. 31:1998;431-435.
43. Noel M.B., Wise R.A. Ventral tegmental injections of morphine but not U50,488H enhance feeding in food-deprived rats. Brain Res. 632:1993;68-73.
44. Ohno M., Yamamoto T., Ueki S. Analgesic and discriminative stimulus properties of U-62,066, the selective kappa-opioid receptor agonist, in the rat. Psychopharmacology (Berlin). 106:1992;31-38.
45. Piercey M.F., Einspahr F.J. Spinal analgesic action of kappa receptor agonists, U50488H and spiradoline (U-62066). J. Pharmacol. Exp. Ther. 251:1989;267-271.
46. Ramarao P., Bhargava H.N. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats. Pharmacol. Biochem. Behav. 33:1989;375-380.
47. Roane D.S., Martin R.J. Continuous sucrose feeding decreases pain threshold and increases morphine potency. Pharmacol. Biochem. Behav. 35:1990;225-229.
48. Roane D.S., Bounds J.K., Ang C.Y., Adloo A.A. Quinpirole-induced alterations of tail temperature appear as hyperalgesia in the radiant heat tail-flick test. Pharmacol. Biochem. Behav. 59:1998;77-82.
49. Romero M.-T., Bodnar R.J. Gender differences in two forms of cold-water swim analgesia. Physiol. Behav. 37:1986;893-897.
50. Rudski J.M., Billington C.J., Levine A.S. A sucrose-based maintenance diet increases sensitivity to appetite suppressant effects of naloxone. Pharmacol. Biochem. Behav. 58:1997;679-682.
51. Sonawane B.R., Coates P.M., Yaffe S.J., Koldovsky O. Influence on dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats. Drug Nutr. Interact. 2:1983;7-16.
52. Von Voigtlander P.F., Lewis R.A. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. J. Pharmacol. Exp. Ther. 246:1988;254-262.
53. Welch C.C., Kim E.-M., Grace M.K., Billington C.J., Levine A.S. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721:1996;126-131.
54. Yeomans M.R. Prior exposure to low or high fat milk enhances naloxone anorexia in rats. Appetite. 20:1993;125-134.
55. Yeomans M.R., Clifton P.G. Exposure to sweetened solutions enhances the anorectic effect of naloxone but not d-fenfluramine. Physiol. Behav. 62:1997;255-262.
56. Yeomans M.R., Wright P., Macleod H.A., Critchley J.A. Effects of nalmefene on feeding in humans. Psychopharmacology (Berlin). 100:1990;426-432.
57. Zhang M., Kelley A.E. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats. Psychopharmacology (Berlin). 132:1997;350-360.